Access Worries Persist after ICER’s Arthritis Report, Meeting
![](https://allianceforpatientaccess.org/wp-content/uploads/2023/11/hand-in-hand-1686811_1920-1024x683.jpg)
A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients.
A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients.